SAN FRANCISCO – Sophie Kornowski-Bonnet wasn't on the same stage that Glaxosmithkline plc CEO Emma Walmsley commanded a day earlier at the 36th Annual J.P. Morgan Healthcare Conference, but the standing-room-only crowd was equally eager to hear the thoughts of the Roche Holding AG official on the future of biopharma development and on her pioneering role as one of the industry's top female business development chiefs.